L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
- 2023-05-27
- RCT · n = 95
- Psychiatry and clinical neurosciences 77(9)
- Mehran Nematizadeh
- Hossein Ghorbanzadeh
- Hossein Sanjari Moghaddam
- Mohammadreza Shalbafan
- Mahsa Boroon
- Amir-Abbas Keshavarz-Akhlaghi
- Shahin Akhondzadeh
- PubMed: 37169515
- DOI: 10.1111/pcn.13565
- High evidence
- Clinical
no significant between-group differences in compulsion subscale scores
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 100 mg twice daily